# Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine

> **NCT01911780** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 132 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** placebo
- **DRUG:** telmisartan + HCTZ
- **DRUG:** telmisartan + HCTZ
- **DRUG:** amlodipine

## Key facts

- **NCT ID:** NCT01911780
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2016-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911780, "Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01911780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*